ArticleBMJ open2020

i-Move, a personalised exercise intervention for patients with advanced melanoma receiving immunotherapy: a randomised feasibility trial protocol.

Amelia Hyatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.